Inari Medical, Inc. (NASDAQ: NARI) reported Q3 EPS of ($0.06), $0.05 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $72.9 million versus the consensus estimate of $63.03 million.

GUIDANCE:

Inari Medical, Inc. sees FY2021 revenue of $266-268 million, versus the consensus of $253 million.

For earnings history and earnings-related data on Inari Medical, Inc. (NARI) click here.